Bioventus Inc(BVS) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 18.89 | EPS (ttm) | 0.78 | Insider Own | 30.83% | Shs Outstand | 68.2M | Perf Week | 2.88% |
| Market Cap | 1.23B | Forward P/E | 15.92 | EPS next Y | 18.17% | Insider Trans | - | Shs Float | 47.3M | Perf Month | 4.64% |
| Enterprise Value | 1.52B | PEG | 0.99 | EPS next Q | 0.15 | Inst Own | 60.09% | Short Float | 6.73% | Perf Quarter | 11.15% |
| Income | 0.05B | P/S | 2.12 | EPS this Y | 14.54% | Inst Trans | 6.72% | Short Ratio | 5.52 | Perf Half Y | 51.5% |
| Sales | 0.58B | P/B | 4.38 | EPS next 5Y | 16.02% | ROA | 7.89% | Short Interest | 3.18M | Perf YTD | 96.91% |
| Book/sh | 3.35 | P/C | 41.82 | EPS past 3/5Y | - 33.74% | ROE | 27.96% | 52W High | -7.82% ($15.89) | Perf Year | 111.1% |
| Cash/sh | 0.35 | P/FCF | 13.16 | Sales past 3/5Y | 3.52% 12.08% | ROIC | 11.61% | 52W Low | 126.43% ($6.47) | Perf 3Y | 345.29% |
| Dividend Est. | - | EV/EBITDA | 14.2 | EPS Y/Y TTM | 19765.85% | Gross Margin | 67.82% | Volatility(W/M) | 3.93% 3.67% | Perf 5Y | -2.14% |
| Dividend TTM | - | EV/Sales | 2.6 | Sales Y/Y TTM | 3.14% | Oper. Margin | 10.56% | ATR (14) | 0.52 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.17 | EPS Q/Q | 333.92% | Profit Margin | 9.36% | RSI (14) | 59.99 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.69 | Sales Q/Q | 3.76% | SMA20 | 6.59% ($13.74) | Beta | 0.65 | Target Price | $17.6 |
| Payout | - | Debt/Eq | 1.16 | Earnings | 2026/11/2 | SMA50 | 6.77% ($13.72) | Rel Volume | 1.03 | Prev Close | $14.42 |
| Employees | 930 | LT Debt/Eq | 1.05 | EPS/Sales Surpr. | 1.71% -1.44% | SMA200 | 35.18% ($10.84) | Avg Volume(3M) | 0.58M | Price | $14.65 |
| IPO | 2021/2/11 | Option/Short | Yes/Yes | Trades | 4467 | Volume | 590,143 | Change | 1.6% |
Bioventus (BVS) is a U.S. medical device company specializing in orthobiologics. Through its portfolio of active healing therapies and surgical products designed to relieve pain and support bone healing, the company helps patients achieve faster, safer recoveries, delivering clinically proven solutions in orthopedics and rehabilitation on a global scale.
Over the past 1 year, on the higher side
8% below its 1-year high.
Traded about as much as usual. That is 103% of its average volume.
Next earnings report: November 2
4 days to go.
BVS makes money exceptionally well
Of every $100 in sales, $10.56 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +14.5% this year.
Tap to view numbers
The price is about the industry average
For a company expected to earn $100 next year, you would pay $1,592. Peers typically go for $1,658.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -2.1%. The S&P 500 did +69% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership looks stable
Institutions hold 60.1%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #37 of 142 in the industry
Based on market cap of $1B.
ENOV#36 Enovis Corp $1B PER - BVS#37 Bioventus Inc $1B PER 18.9 
PRCT#38 Procept BioRobotics Corp $1B PER - 
AORT#39 Artivion Inc $1B PER - 
LMRI#40 Lumexa Imaging Holdings Inc $1B PER - 
FAQ
What kind of company is BVS?
BVS belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of BVS?
The market cap of BVS is approximately $1.2B, ranking 2,432 within its sector.
What is the P/E ratio of BVS?
BVS has a P/E ratio of approximately 18.9x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for BVS?
BVS has recorded a 52-week high of $15.89 and a low of $6.47.
